Vikram Purohit analyst MORGAN STANLEY

Currently out of the existing stock ratings of Vikram Purohit, 56 are a BUY (42.11%), 74 are a HOLD (55.64%), 3 are a SELL (2.26%).

Vikram Purohit

Work Performance Price Targets & Ratings Chart

Analyst Vikram Purohit, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 47.33% that have a potential upside of 45.34% achieved within 118 days.

Vikram Purohit’s has documented 306 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INCY, yte at 30-Oct-2024.

Wall Street Analyst Vikram Purohit

Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS ).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 12/21/2023. The price target of $11 was fulfilled within 71 days with a profit of $8.4 (323.08%) receiving and performance score of 45.5.

Average potential price target upside

AXSM Axsome Therapeutics CERT Certara FHTX Foghorn Therapeutics  HOOK Hookipa Pharma INCY yte KYMR Kymera Therapeutics RDUS Schnitzer Steel Industries SAGE Sage Therapeutic TALS Talaris Therapeutics TBPH Theravance Biopharma EVLO Evelo Biosciences EXAI Exscientia Ltd ADR TIL Instil Bio . RGNX Regenxbio SDGR Schrodinger ARQT Arcutis Biotherapeutics  ASND Ascendis Pharma AS AKLI Akili HALO Halozyme Therapeutics BMRN Biomarin Pharmaceutical

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$107

$13.83 (14.84%)

$107

2 months ago
(20-Sep-2024)

7/20 (35%)

$11.16 (11.64%)

49

Buy

$180

$86.83 (93.20%)

$180

2 months 15 days ago
(05-Sep-2024)

6/29 (20.69%)

$86.31 (92.12%)

108

Hold

$106

$12.83 (13.77%)

$95

3 months 14 days ago
(06-Aug-2024)

5/7 (71.43%)

$20.48 (23.95%)

50

Buy

$105

$11.83 (12.70%)

$111

3 months 14 days ago
(06-Aug-2024)

1/3 (33.33%)

$19.48 (22.78%)

157

Buy

$106

$12.83 (13.77%)

$106

5 months 8 days ago
(12-Jun-2024)

8/16 (50%)

$34.45 (48.15%)

148

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Vikram Purohit is most bullish on?

Potential upside of $18.35 has been obtained for HALO (HALOZYME THERAPEUTICS)

Which stock is Vikram Purohit is most reserved on?

Potential downside of -$6.87 has been obtained for INCY (YTE)

What Year was the first public recommendation made by Vikram Purohit?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?